Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Ell

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|April 7, 2011
What is the relationship between ¹⁸F-FDG aortic aneurysm uptake on PET/CT and future growth rate?Carl W Kotze, Ashley M Groves, Leon J Menezes, et al.
Psychopharmacology|January 8, 2008
Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [(123)I]CNS-1261 SPET studyJames M Stone, Kjell Erlandsson, Erik Arstad, et al.
Nuclear Medicine and Biology|May 28, 2003
Kinetic modelling of [123I]CNS 1261--a potential SPET tracer for the NMDA receptorKjell Erlandsson, Rodrigo A Bressan, Rachel S Mulligan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2010
¹⁸F-FDG PET and biomarkers for tumour angiogenesis in early breast cancerAshley M Groves, Manu Shastry, Manuel Rodriguez-Justo, et al.
Urology|May 12, 2004
Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancerOliver Sartor, Robert H Reid, Peter J Hoskin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2009
Vascular inflammation imaging with 18F-FDG PET/CT: when to image?Leon J Menezes, Carl W Kotze, Brian F Hutton, et al.
BJU International|February 9, 2008
Stage migration and pilot studies of reduced chemotherapy supported by positron-emission tomography findings suggest new combined strategies for stage 2 nonseminoma germ cell tumourYasser Haba, Michael V Williams, David E Neal, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 7, 2005
Oral contrast medium in PET/CT: should you or shouldn't you?Ashley M Groves, Irfan Kayani, John C Dickson, et al.
Nuclear Medicine and Biology|March 12, 2004
A bolus/infusion paradigm for the novel NMDA receptor SPET tracer [123I]CNS 1261Rodrigo A Bressan, Kjell Erlandsson, Rachel S Mulligan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 27, 2008
Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CTAshley M Groves, Gordon C Wishart, Manu Shastry, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
European Journal of Nuclear Medicine and Molecular Imaging|April 7, 2011
What is the relationship between ¹⁸F-FDG aortic aneurysm uptake on PET/CT and future growth rate?Carl W Kotze, Ashley M Groves, Leon J Menezes, et al.
Psychopharmacology|January 8, 2008
Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [(123)I]CNS-1261 SPET studyJames M Stone, Kjell Erlandsson, Erik Arstad, et al.
Nuclear Medicine and Biology|May 28, 2003
Kinetic modelling of [123I]CNS 1261--a potential SPET tracer for the NMDA receptorKjell Erlandsson, Rodrigo A Bressan, Rachel S Mulligan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2010
¹⁸F-FDG PET and biomarkers for tumour angiogenesis in early breast cancerAshley M Groves, Manu Shastry, Manuel Rodriguez-Justo, et al.
Urology|May 12, 2004
Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancerOliver Sartor, Robert H Reid, Peter J Hoskin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2009
Vascular inflammation imaging with 18F-FDG PET/CT: when to image?Leon J Menezes, Carl W Kotze, Brian F Hutton, et al.
BJU International|February 9, 2008
Stage migration and pilot studies of reduced chemotherapy supported by positron-emission tomography findings suggest new combined strategies for stage 2 nonseminoma germ cell tumourYasser Haba, Michael V Williams, David E Neal, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 7, 2005
Oral contrast medium in PET/CT: should you or shouldn't you?Ashley M Groves, Irfan Kayani, John C Dickson, et al.
Nuclear Medicine and Biology|March 12, 2004
A bolus/infusion paradigm for the novel NMDA receptor SPET tracer [123I]CNS 1261Rodrigo A Bressan, Kjell Erlandsson, Rachel S Mulligan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 27, 2008
Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CTAshley M Groves, Gordon C Wishart, Manu Shastry, et al.
Pageof 10